Cargando…
Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation
BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. W...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565654/ https://www.ncbi.nlm.nih.gov/pubmed/28444455 http://dx.doi.org/10.1007/s00392-017-1119-9 |
_version_ | 1783258424053596160 |
---|---|
author | Abdelghani, Mohammad Cavalcante, Rafael Miyazaki, Yosuke de Winter, Robbert J. Sarmento-Leite, Rogério Mangione, José A. Abizaid, Alexandre Lemos, Pedro A. Serruys, Patrick W. de Brito, Fabio S. |
author_facet | Abdelghani, Mohammad Cavalcante, Rafael Miyazaki, Yosuke de Winter, Robbert J. Sarmento-Leite, Rogério Mangione, José A. Abizaid, Alexandre Lemos, Pedro A. Serruys, Patrick W. de Brito, Fabio S. |
author_sort | Abdelghani, Mohammad |
collection | PubMed |
description | BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI. METHODS AND RESULTS: Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p < 0.001 and 2.16 (95% CI: 1.08–4.35), p = 0.030, respectively]. Even mild residual functional impairment (NYHA II) was associated with a higher all-cause [HR: 2.02 (95% CI: 1.10–3.72), p = 0.023] and cardiac [HR: 2.08 (95% CI: 1.42–3.07), p < 0.001] mortality. CONCLUSION: Residual impairment of functional capacity is common after TAVI and is independently associated with increased mortality. Predictors of residual impairment of functional status are predominantly patient-rather than procedure-related. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-017-1119-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5565654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-55656542017-09-06 Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation Abdelghani, Mohammad Cavalcante, Rafael Miyazaki, Yosuke de Winter, Robbert J. Sarmento-Leite, Rogério Mangione, José A. Abizaid, Alexandre Lemos, Pedro A. Serruys, Patrick W. de Brito, Fabio S. Clin Res Cardiol Original Paper BACKGROUND: Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI. METHODS AND RESULTS: Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p < 0.001 and 2.16 (95% CI: 1.08–4.35), p = 0.030, respectively]. Even mild residual functional impairment (NYHA II) was associated with a higher all-cause [HR: 2.02 (95% CI: 1.10–3.72), p = 0.023] and cardiac [HR: 2.08 (95% CI: 1.42–3.07), p < 0.001] mortality. CONCLUSION: Residual impairment of functional capacity is common after TAVI and is independently associated with increased mortality. Predictors of residual impairment of functional status are predominantly patient-rather than procedure-related. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00392-017-1119-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-04-25 2017 /pmc/articles/PMC5565654/ /pubmed/28444455 http://dx.doi.org/10.1007/s00392-017-1119-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Paper Abdelghani, Mohammad Cavalcante, Rafael Miyazaki, Yosuke de Winter, Robbert J. Sarmento-Leite, Rogério Mangione, José A. Abizaid, Alexandre Lemos, Pedro A. Serruys, Patrick W. de Brito, Fabio S. Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title | Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title_full | Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title_fullStr | Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title_full_unstemmed | Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title_short | Prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
title_sort | prevalence, predictors, and prognostic implications of residual impairment of functional capacity after transcatheter aortic valve implantation |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565654/ https://www.ncbi.nlm.nih.gov/pubmed/28444455 http://dx.doi.org/10.1007/s00392-017-1119-9 |
work_keys_str_mv | AT abdelghanimohammad prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT cavalcanterafael prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT miyazakiyosuke prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT dewinterrobbertj prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT sarmentoleiterogerio prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT mangionejosea prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT abizaidalexandre prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT lemospedroa prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT serruyspatrickw prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation AT debritofabios prevalencepredictorsandprognosticimplicationsofresidualimpairmentoffunctionalcapacityaftertranscatheteraorticvalveimplantation |